BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2012
View Archived Issues
Researchers at IRM patent novel Trk-A inhibitors
Read More
New glucagon GLP-1 receptor agonists designed in China
Read More
U.S. university presents new antibacterials
Read More
Bristol-Myers Squibb develops novel candidate influenza drugs
Read More
Novel c-Met inhibitors reported
Read More
New orally bioavailable TTK inhibitor described
Read More
Scientists in U.S. develop new mouse model to study radiation effects
Read More
Tetraphase Pharmaceuticals describes antibacterial activity of novel pentacycline
Read More
First-in-human data presented on hypomethylating anticancer agent
Read More
Amgen reports discovery of novel class of prostanoid EP2 receptor antagonists
Read More
Nuron Biotech obtains worldwide license for candidate AD vaccine
Read More
Orphan drug status granted to ReGenX BioSciences program
Read More
European Commission approves Humira for new indication
Read More
Wilex begins phase Ib/II study of WX-554
Read More
Enzo Biochem launches test to assess colorectal cancer risk
Read More
MacuCLEAR to advance MC-1101 to phase III development
Read More
NeurOp obtains NIH grant for schizophrenia drug research
Read More
Novel products for cognitive disorders discovered at Mithridion
Read More
SkyePharma signs second development contract with RespiVert
Read More
Merck & Co. discovers new potential schizophrenia therapies
Read More
NIH to evaluate Isotechnika Pharma portfolio
Read More
New Quest Diagnostics molecular test cleared by FDA
Read More
IntegraGen launches tool to assess autism in children at high risk
Read More
Lilly obtains approval in Canada for testosterone replacement therapy
Read More
RiboMed launches new prognostic test for grading gliomas
Read More
GE Healthcare reports phase III data on flutemetamol (18F)
Read More
Fampyra launched in Canada
Read More